Daniel Sasca

996 citations

20 papers · 473 indexed · h-index 8

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine

Papers in ⓘ

Hematology 12
- Acute Myeloid Leukemia Research 10
Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3

Co-authors: Thomas Kindler (8 shared papers)Matthias Theobald (7 shared papers)Patricia S. Hähnel (4 shared papers)Lars Bullinger (4 shared papers)Oliver Kriege (3 shared papers)George S. Vassiliou (4 shared papers)George Giotopoulos (5 shared papers)Brian J.P. Huntly (5 shared papers)
Journals: Blood (11 papers)Journal of Clinical Oncology (2 papers)Journal of Innate Immunity (1 paper)Current Opinion in Hematology (1 paper)International Journal of Cancer (1 paper)
Partner nations: Germany United States United Kingdom

In The Last Decade

Daniel Sasca

19 papers receiving 468 citations

Peers

Countries citing papers authored by Daniel Sasca

Since Specialization

Citations

This map shows the geographic impact of Daniel Sasca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sasca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sasca more than expected).

Fields of papers citing papers by Daniel Sasca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sasca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sasca. The network helps show where Daniel Sasca may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Sasca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Sasca Line = papers co-authored together Daniel Sasca links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition Blood ·Paolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis, Ana S.H. Costa, Shabana Vohra, Paula Medina-Pérez, Faisal Basheer, Ludovica Marando, Lorena Di Lisio, João M.L. Dias, Haiyang Yun, Daniel Sasca, Sarah J. Horton, George S. Vassiliou, Christian Frezza, Brian J.P. Huntly	2018	101
2	SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia Blood ·Daniel Sasca, Patricia S. Hähnel, Jakub Szybinski, Kaml I.K. Khawaja, Oliver Kriege, Saskia V. Pante, Lars Bullinger, Susanne Strand, Dennis Strand, Matthias Theobald, Thomas Kindler	2014	90
3	Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition Blood ·Margarita M. Dzama, Marlene Steiner, Johanna Rausch, Daniel Sasca, Jonas Schönfeld, Kerstin Kunz, Martha C. Taubert, Gerard M. McGeehan, Chun‐Wei Chen, Annalisa Mupo, Patricia S. Hähnel, Matthias Theobald, Thomas Kindler, Richard P. Koche, George S. Vassiliou, Scott A. Armstrong, Michael W.M. Kühn	2020	79
4	NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML Blood ·Daniel Sasca, Jakub Szybinski, Andrea Schüler, Viral Shah, Jan B. Heidelberger, Patricia S. Haehnel, Anna Dolnik, Oliver Kriege, Eva-Marie Fehr, Wolf Henning Gebhardt, George Reid, Claudia Scholl, Matthias Theobald, Lars Bullinger, Petra Beli, Thomas Kindler	2019	52
5	Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies Blood ·Daniel Sasca, Haiyang Yun, George Giotopoulos, Jakub Szybinski, Theodore Evan, Nicola K. Wilson, Moritz Gerstung, Paolo Gallipoli, Anthony R Green, Robert K. Hills, Nigel H. Russell, Cameron S. Osborne, Elli Papaemmanuil, Berthold Göttgens, Peter J. Campbell, Brian J.P. Huntly	2019	39
6	Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy Blood ·Patricia S. Hähnel, Birgit Enders, Daniel Sasca, Wynand P. Roos, Bernd Kaina, Lars Bullinger, Matthias Theobald, Thomas Kindler	2014	35
7	Distinct Signaling Cascades of TREM-1, TLR and NLR in Neutrophils and Monocytic Cells Journal of Innate Immunity ·Steve Prüfer, Michael Weber, Daniel Sasca, Daniel Teschner, Catherine Wölfel, Pamela Stein, Michael Stassen, Hansjörg Schild, Markus P. Radsak	2013	29
8	STAT5 Is Crucial to Maintain Leukemic Stem Cells in Acute Myelogenous Leukemias Induced by MOZ-TIF2 Cancer Research ·Winnie F. Tam, Patricia S. Hähnel, Andrea Schüler, Benjamin H. Lee, Rachel Okabe, Nan Zhu, Saskia V. Pante, Glen Raffel, Thomas Mercher, Gerlinde Wernig, Ernesto Bockamp, Daniel Sasca, Andreas Kreft, Gertraud W. Robinson, Lothar Hennighausen, D. Gary Gilliland, Thomas Kindler	2012	26
9	HOXA9 forms a repressive complex with nuclear matrix–associated protein SAFB to maintain acute myeloid leukemia Blood ·Shuchi Agrawal‐Singh, Jaana Bagri, George Giotopoulos, Dhoyazan Azazi, Sarah J. Horton, Cécile K. Lopez, Shubha Anand, Anne-Sophie Bach, Frances Stedham, Robin Antrobus, Jack W. Houghton, George S. Vassiliou, Daniel Sasca, Haiyang Yun, Anthony D. Whetton, Brian J.P. Huntly	2022	5
10	Early Loss of CREBBP Confers Malignant Stem Cell Properties on Lymphoid Progenitors Blood ·Brian J.P. Huntly, Sarah J. Horton, George Giotopoulos, Haiyang Yun, Shabana Vohra, Olivia Sheppard, Rachael Bashford-Rogers, Mamunur Rashid, Daniel Sasca, Faisal Basheer, Paolo Gallipoli, Jessica Okosun, Daniel J. Hodson, Jude Fitzgibbon, Ming‐Qing Du, David J. Adams	2016	4
11	Deficiency of Antioxidative Paraoxonase 2 (Pon2) Leads to Increased Number of Phenotypic LT‐HSCs and Disturbed Erythropoiesis Oxidative Medicine and Cellular Longevity ·Lisa Spiecker, Ines Witte, Julia Mehlig, Viral Shah, Markus Meyerhöfer, Patricia S. Haehnel, Victoria M. Petermann, Andrea Schüler, Piyush More, Nina Cabezas‐Wallscheid, Sven Horke, Andrea Pautz, Andreas Daiber, Daniel Sasca, Thomas Kindler, Hartmut Kleinert	2021	3
12	Mutational Synergy Coordinately Remodels Chromatin Accessibility, Enhancer Landscape and 3-Dimensional DNA Topology to Alter Gene Expression during Leukemia Induction Blood ·Haiyang Yun, Shabana Vohra, Annalisa Mupo, George Giotopoulos, Daniel Sasca, Sarah J. Horton, Shuchi Agrawal‐Singh, Eshwar Meduri, Faisal Basheer, Ludovica Marando, Malgorzata Gozdecka, Oliver M. Dovey, Xiaonan Wang, Paolo Gallipoli, Cameron S. Osborne, George S. Vassiliou, Brian J.P. Huntly	2019	2
13	Next generation epigenetic modulators to target myeloid neoplasms Current Opinion in Hematology ·Daniel Sasca, Borhane Guezguez, Michael W.M. Kühn	2021	2
14	Therapeutic targeting of chromatin alterations in leukemia and solid tumors International Journal of Cancer ·Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W.M. Kühn, Michael Lübbert	2025	1
15	VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV). Journal of Clinical Oncology ·Aniket Bankar, Kristen Pettit, Joseph J. Shatzel, Abdulraheem Yacoub, Naveen Pemmaraju, Harinder Gill, Antonín Hluší, Alessandro Lucchesi, Samah Alimam, Jiří Mayer, Francesca Palandri, Daniel Sasca, Katharina Modelska, Suneel Gupta, Ifode Ajari, Sarita Khanna, Arturo Molina, Andrew Kuykendall	2024	1
16	MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients Annals of Hematology ·Stefanie Jilg, Juliana Schwaab, Katja Sockel, Carl C. Crodel, Valeska Brueckl, Frank Stegelmann, Madlen Jentzsch, Daniel Sasca, Margarete Moyses, Stephan Fuhrmann, Daniel Gündel, Madlen Caduc, Lino L. Teichmann, Florian Heidel, Haifa Kathrin Al‐Ali, Petro E Petrides	2024	1
17	Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia Blood ·Daniel Sasca, A. Schueler, Jakub Szybinski, Oliver Kriege, Kerstin Kunz, Eva Marie Fehr, Patricia S. Haehnel, Wolf Henning Gebhardt, G K Reid, Matthias Theobald, Lars Bullinger, Thomas Kindler	2015	1
18	Treatment-Induced Aggravation of Vasculitis in Hairy-Cell Leukemia Clinical Lymphoma Myeloma & Leukemia ·Johanna Rausch, Johannes Windschmitt, Carolin Schilling, Florian Butsch, Matthias Theobald, Daniel Sasca, Georg Heß	2020	1
19	The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax Blood ·Johanna Rausch, Margarita M. Dzama, Nadezda Dolgikh, Hanna Stiller, Stephan Bohl, Catharina Lahrmann, Kerstin Kunz, Linda Kessler, Hakim Echchannaoui, Chun‐Wei Chen, Thomas Kindler, Francis Burrows, Matthias Theobald, Daniel Sasca, Scott A. Armstrong, Michael R. Kuehn	2022	1
20	Results from VERIFY, a phase 3, double-blind, placebo (PBO)-controlled study of rusfertide for treatment of polycythemia vera (PV). Journal of Clinical Oncology ·Andrew Kuykendall, Naveen Pemmaraju, Kristen Pettit, Joseph J. Shatzel, Alessandro Lucchesi, Valentín García‐Gutiérrez, Jiří Mayer, Abdulraheem Yacoub, Harinder Gill, Antonín Hluší, Daniel Sasca, Joseph M. Scandura, Marina Kremyanskaya, Phil Dinh, Sarita Khanna, Suneel K. Gupta, Arturo Molina, Aniket Bankar, (unknown)	2025	0

About Daniel Sasca

Daniel Sasca is a scholar working on Hematology, Genetics, Geriatrics and Gerontology, Molecular Biology and Clinical Biochemistry, having authored 20 papers that have together received 473 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Protein Degradation and Inhibitors (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Genomics and Chromatin Dynamics (3 papers), Cancer-related gene regulation (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Epigenetics and DNA Methylation (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (210 citations), Geriatrics and Gerontology (45 citations), Cancer Research (89 citations), Molecular Biology (307 citations) and Genetics (40 citations). Daniel Sasca has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thomas Kindler, Matthias Theobald, Patricia S. Hähnel, Lars Bullinger, Oliver Kriege, George S. Vassiliou, George Giotopoulos, Brian J.P. Huntly, Paolo Gallipoli and Haiyang Yun. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Innate Immunity, Current Opinion in Hematology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact